Clinical Trial Update: A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [Phase 2]

View source ↗

Summary

Phase II multicenter study comparing seroconversion after single-dose versus two-dose measles vaccination in HIV-infected and uninfected children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Measles

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Measles | Phase 2 | Status: COMPLETED